China's CanSinoBIO says Mexico approves COVID-19 vaccine for emergency use
FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc
Read more